Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |